Results

Total Results: 2,231 records

Showing results for "disease".

321. Liver-Cancer-Therapy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
     November 28, 2012 - HCC is a highly lethal disease, and worldwide it is the fifth most common cancer and the third leading … Disease is staged from 0 to D. … Patients with chronic liver disease are classified as Child-Pugh class A, B, or C based upon the total … Another scoring system for chronic liver disease is the Model for End-Stage Liver Disease (MELD) score … In addition, the use of various disease classification systems and the inability to translate disease

322. High-Cholestorol-Medicines-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
     February 01, 2014 - valve disease, congenital heart disease, and hypertension. … (CHD), cerebrovascular disease, and peripheral artery disease. … CHD = coronary heart disease; FDA = U.S. … without preexisting cardiovascular disease. … Reduced or modified dietary fat for preventing cardiovascular disease.

323. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
     March 01, 2013 - Surveillance Report: March 2013 Key Findings: - Key Question 1: Conclusion regarding biologic Disease … Compared with placebo in one good systematic review study, sulfasalazine reduced disease activity. … factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases … INTERNAL MEDICINE BMJ JAMA LANCET NEW ENGLAND JOURNAL OF MEDICINE ANNALS OF THE RHEUMATIC DISEASES … Do Not Know KQ 1: For patients with PsA, do drug therapies differ in their ability to reduce disease

324. Ahrq Community Forum Webinar Branson (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_branson.pdf
     October 13, 2011 - SRA. 4 Characteristics of Patient Representatives • Have personal experience with the disease … • Are knowledgeable about treatment options and/or the science of the disease • Are able to be … groups may offer an opportunity to identify patients who might be underrepresented (such as for rare diseases … Advocacy experience – Ability to represent other patients/survivors – Knowledge and skills related to disease … area – Alternate disease experience – Work experience – Education • Interview representatives

325. Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
     November 19, 2009 - from non-disease. … At that time, vidarabine was proven an effective yet toxic treatment for the disease, which has high … Exploring Hypothetical Conditions for Diseases With No Effective Treatment As mentioned before, a … The “disease” is then an arbitrary construct that may or may not correspond to different prognoses. … The MISCAN simulation program for the evaluation of screening for disease.

326. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
     March 17, 2020 - assessed to determine efficacy related to health outcomes for consumers with (or at risk for) chronic diseases … obstructive pulmonary disease, or asthma. … Which specific chronic diseases do you think are most important for us to include? 3. … challenge to interpreting research and evaluation studies on consumer health technologies for chronic diseases … 'coronary artery disease'/exp OR (coronar*:ti AND arter*:ti AND (disease*:ti OR syndrome*:ti OR atheroscleros

327. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
     January 01, 2010 - PCI procedure codes (International Classification of Diseases, Ninth Revision, Clinical Modification … 2 Vessel Disease 3 Vessel Disease 2004 PCI 2005 PCI 2006 PCI Overall .5 .6 .75 1 1.25 1.5 2 Death … 2 Vessel Disease 3 Vessel Disease 2004 PCI 2005 PCI 2006 PCI Overall .5 .6 .75 1 1.25 1.5 2 Myocardial … 2 Vessel Disease 3 Vessel Disease 2004 PCI 2005 PCI 2006 PCI Overall .5 .6 .75 1 1.25 1.5 2 Major … 2 Vessel Disease 3 Vessel Disease 2004 PCI 2005 PCI 2006 PCI Overall .5 .6 .75 1 1.25 1.5 2 Stroke

328. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
     January 01, 2007 - affects 1 percent of the U.S. adult population (or upwards of 2 million individuals), is an autoimmune disease … The disease tends to affect the small joints of the hands and feet in a symmetric pattern, but other … PsA is associated with the skin disease psoriasis. … Available therapies for RA include corticosteroids; synthetic disease-modifying antirheumatic drugs, … However, all arms had similar disease activity by disease activity score (DAS) values at 2 years regardless

329. Coronary-Artery-Stenting Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
     February 01, 2013 - and intermediate coronary stenosis, excluding left main disease and acute MI. … IVUS or no IVUS groups, irrespective of variations in anatomic left main disease. … and intermediate coronary stenosis, excluding left main disease and acute MI. … and lower grade angina, and excluded patients with left main disease and acute MI … patients with left main disease.

330. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
     January 01, 2011 - no underlying kidney disease. … Bethesda, MD, National Institute of Diabetes and Digestive and Kidney Diseases; 2010. … Correction of anemia with epoetin alfa in chronic kidney disease. … Clinical aspects of iron use in the anemia of kidney disease. … hemodialysis.af. 41,409 62 peritoneal dialysis.mp. or exp Peritoneal Dialysis/ 23,533 63 exp Kidney Diseases

331. Bar-Cohen_ ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/bar-cohen_-eccs2012.pdf
     January 01, 2012 - o Understand what the outcome is (getting disease, dying from  disease, developing  a symptom), … Explain the number of people with the disease, and always include “Out of how many?” … to illustrate the chance of the disease.

332. Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-meta-analysis.ppt
     June 01, 2012 - Patients in the “With Disease” category actually have the disease of interest, and those in the “Healthy … If a patient is in the “With Disease” category and tests positive for the disease using the test of interest … who will test positive for the disease. … Specificity is the proportion of people without disease who test negative for the disease. … of the test being positive in people without a disease.

333. Meta-analysis of Test Performance Evidence When There is a “Gold Standard” Reference Standard (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-meta-analysis.ppt
     June 01, 2012 - Patients in the “With Disease” category actually have the disease of interest, and those in the “Healthy … If a patient is in the “With Disease” category and tests positive for the disease using the test of interest … who will test positive for the disease. … Specificity is the proportion of people without disease who test negative for the disease. … of the test being positive in people without a disease.

334. Prostate-Cancer-Risk-Assessment-Genes Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
     July 01, 2012 - An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and … Risks and benefits of population-based genetic testing for Mendelian subsets of common diseases were … How many genes underlie the occurrence of common complex diseases in the population? … Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. … Research priorities for evaluating family history in the prevention of common chronic diseases.

335. Quantitative Synthesis II: Interactive Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
     May 29, 2025 - review to compare percutaneous coronary intervention with coronary artery bypass graft for coronary disease … Panel has raised concerns that these 23 trials enrolled patients with a relatively narrow spectrum of disease … (CER) to compare percutaneous coronary intervention with coronary artery bypass graft for coronary disease … Panel has raised concerns that these 23 trials enrolled patients with a relatively narrow spectrum of disease

336. Quantitative Synthesis II: Interactive Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
     May 29, 2025 - review to compare percutaneous coronary intervention with coronary artery bypass graft for coronary disease … Panel has raised concerns that these 23 trials enrolled patients with a relatively narrow spectrum of disease … (CER) to compare percutaneous coronary intervention with coronary artery bypass graft for coronary disease … Panel has raised concerns that these 23 trials enrolled patients with a relatively narrow spectrum of disease

337. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
     August 18, 2011 - chronic disease. … For this reason, and because their longer duration means chronic diseases cause greater disease burden … Among patients with chronic diseases with self-administered medication prescribed by a provider, what … Among patients with chronic diseases with self-administered medication prescribed by a provider, what … Noncommunicable Diseases and Mental Health Cluster.

338. EHC Research Protocol: Management of Colonic Diverticulitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diverticulitis-research-protocol.pdf
     January 01, 2019 - Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. … Treatment of perforated diverticular disease of the colon. Adv Surg. 1978;12:85-109. … Prevention and Conservative Therapy of Diverticular Disease. … Role of Fiber in Symptomatic Uncomplicated Diverticular Disease: A Systematic Review. … Diagnosis and management of diverticular disease of the colon in adults.

339. Renal-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
     April 20, 2015 - Diagnostic Evaluation and Detection of Disease All solid renal masses and cystic lesions with solid … Patients with surgical chronic kidney disease (defined as chronic kidney disease as a result of surgical … resulting from medical renal disease. … syndromes and predictors of advanced/metastatic disease (e.g. … Mullins, J.K., et al., Tumor complexity predicts malignant disease for small renal masses.

340. Evaluating Practices and Developing Tools for Comparative Effectiveness Reviews of Diagnostic Test Accuracy: Methods for the Joint Meta-Analysis of Multiple Tests (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diagnostic-tests-accuracy_research.pdf
     January 01, 2013 - Notation for observed counts and estimated probabilities in those with disease (D) and without disease … and individuals without disease). … and those without disease). … ) in study k Test Results Disease No Disease Negative (–) π D D k , 0 π k , 0 Positive (+) … ) and without disease (D ) in study k Test Results Disease, Counts Disease, Estimated Probabilities